Search

Search Constraints

You searched for: Author/Creator Hober, Sophia

Search Results

1. 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection. Issue 2 (February 2023)

2. A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells. Issue 10 (2nd September 2022)

3. Antibody performance in western blot applications is context‐dependent. Issue 3 (29th January 2014)

4. B‐cell repopulation dynamics and drug pharmacokinetics impact SARS‐CoV‐2 vaccine efficacy in anti‐CD20‐treated multiple sclerosis patients. (20th July 2022)

5. Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m. Issue 1 (December 2017)

6. Correction to: Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys. (21st July 2022)

7. Enhanced validation of antibodies for research applications. Issue 1 (December 2018)

8. High Amounts of SARS-CoV-2 Precede Sickness Among Asymptomatic Health Care Workers. (13th February 2021)

9. Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection. Issue 7 (July 2022)

10. Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time. Issue 4 (18th April 2022)